Skip to main content

Fluperlapine









Fluperlapine


From Wikipedia, the free encyclopedia

Jump to navigation
Jump to search


















































Fluperlapine
Fluperlapine.svg
Clinical data
ATC code
  • none
Identifiers
CAS Number

  • 67121-76-0 ☒N

PubChem CID
  • 49381
ChemSpider

  • 44882 ☑Y
UNII
  • EWG253M961
ChEMBL

  • ChEMBL63756 ☑Y
Chemical and physical data
Formula
C19H20FN3
Molar mass 309.381 g/mol
3D model (JSmol)
  • Interactive image

.mw-parser-output .nobold{font-weight:normal}
 ☒N☑Y (what is this?)
  (verify)

Fluperlapine (NB 106-689), also known as fluoroperlapine, is a morphanthridine (11H-dibenzo[b,e]azepine
) atypical antipsychotic with additional antidepressant and sedative effects. It was first synthesized in 1979, and then subsequently studied in animals and humans in 1984 and beyond,[1] but despite demonstrating efficacy in the treatment of a variety of medical conditions including schizophrenia,[2][3][4][5]psychosis associated with Parkinson's disease,[6]depressive symptoms, and dystonia,[7] it was never marketed.[1]
This was perhaps due to its capacity for producing potentially life-threatening agranulocytosis, similarly to clozapine,[8] which it closely resembles both structurally and pharmacologically.



Pharmacology[edit]


Binding profile[9]



























































Receptor Ki (nM)
5-HT2A
 7.9
5-HT2C
 18.2
5-HT6
 29
5-HT7
 4.6
M1
 8.8
M2
 71
M3
 41
M4
 14
M5
 17
D1
 85
D2
 316.2
D3
 254.7
D4
 21


See also[edit]



  • Clozapine

  • Perlapine



References[edit]





  1. ^ ab
    Ganellin, C. R.; Triggle, D. J.; Macdonald, F. (1997). Dictionary of pharmacological agents. CRC Press. p. 916. ISBN 978-0-412-46630-4. Retrieved 15 September 2011..mw-parser-output cite.citation{font-style:inherit}.mw-parser-output q{quotes:"""""""'""'"}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-lock-free a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-lock-limited a,.mw-parser-output .cs1-lock-registration a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-lock-subscription a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}


  2. ^
    Fischer-Cornelssen, K. A. (1984). "Fluperlapine in 104 schizophrenic patients. Open multicenter trial". Arzneimittel-Forschung. 34 (1A): 125–130. PMID 6145428.


  3. ^
    Woggon, B.; Angst, J.; Bartels, M.; Heinrich, K.; Hippius, H.; Koukkou, M.; Krebs, E.; Küfferle, B.; Müller-Oerlinghausen, B.; Pöldinger, W.; rÜTher, E.; Schied, H. W. (1984). "Antipsychotic efficacy of fluperlapine. An open multicenter trial". Neuropsychobiology. 11 (2): 116–120. doi:10.1159/000118064. PMID 6148712.


  4. ^
    Dieterle, D.; Eben, E.; Einhäupl, K.; Hippius, H.; Klein, H.; Rüther, E.; Schmauß, M. (2008). "The Effect of Fluperlapine in Acute Psychotic Patients". Pharmacopsychiatry. 17 (2): 57–60. doi:10.1055/s-2007-1017408. PMID 6728910.


  5. ^
    Woggon, B.; Heinrich, K.; Küfferle, B.; Müller-Oerlinghausen, B.; Pöldinger, W.; Rüther, E.; Schied, H. W. (1984). "Results of a multicenter AMDP study with fluperlapine in schizophrenic patients". Arzneimittel-Forschung. 34 (1A): 122–124. PMID 6145427.


  6. ^ Scholz, E.; Dichgans, J. (1985). "Treatment of drug-induced exogenous psychosis in parkinsonism with clozapine and fluperlapine". European Archives of Psychiatry and Neurological Sciences. 235 (1): 60–64. doi:10.1007/bf00380972. PMID 2864254.


  7. ^
    Pakkenberg, H.; Pedersen, B. (1985). "Medical treatment of dystonia". Psychopharmacology. Supplementum. Psychopharmacology Supplementum. 2: 111–117. doi:10.1007/978-3-642-70140-5_14. ISBN 978-3-642-70142-9. ISSN 0179-8456. OCLC 10642795. PMID 2860654.


  8. ^ Lai, W. G.; Gardner, I.; Zahid, N.; Uetrecht, J. P. (2000). "Bioactivation and covalent binding of hydroxyfluperlapine in human neutrophils: Implications for fluperlapine-induced agranulocytosis". Drug Metabolism and Disposition. 28 (3): 255–263. PMID 10681368.


  9. ^ Roth, BL; Driscol, J (12 January 2011). "PDSP Ki Database". Psychoactive Drug Screening Program (PDSP). University of North Carolina at Chapel Hill and the United States National Institute of Mental Health. Archived from the original on 8 November 2013. Retrieved 3 December 2013.














Retrieved from "https://en.wikipedia.org/w/index.php?title=Fluperlapine&oldid=833473384"





Navigation menu

























(window.RLQ=window.RLQ||).push(function(){mw.config.set({"wgPageParseReport":{"limitreport":{"cputime":"1.068","walltime":"1.281","ppvisitednodes":{"value":5471,"limit":1000000},"ppgeneratednodes":{"value":0,"limit":1500000},"postexpandincludesize":{"value":552001,"limit":2097152},"templateargumentsize":{"value":153263,"limit":2097152},"expansiondepth":{"value":16,"limit":40},"expensivefunctioncount":{"value":4,"limit":500},"unstrip-depth":{"value":1,"limit":20},"unstrip-size":{"value":27390,"limit":5000000},"entityaccesscount":{"value":4,"limit":400},"timingprofile":["100.00% 708.607 1 -total"," 52.48% 371.868 1 Template:Drugbox"," 36.66% 259.774 1 Template:Infobox"," 27.53% 195.073 1 Template:Reflist"," 23.40% 165.848 26 Template:Navbox"," 15.78% 111.838 1 Template:Navboxes"," 12.96% 91.821 7 Template:Cite_journal"," 12.77% 90.495 16 Template:Unbulleted_list"," 10.79% 76.472 1 Template:Cite_book"," 6.98% 49.430 1 Template:Serotonin_receptor_modulators"]},"scribunto":{"limitreport-timeusage":{"value":"0.301","limit":"10.000"},"limitreport-memusage":{"value":5470123,"limit":52428800}},"cachereport":{"origin":"mw1270","timestamp":"20181215044805","ttl":1900800,"transientcontent":false}}});mw.config.set({"wgBackendResponseTime":119,"wgHostname":"mw1274"});});
-

Popular posts from this blog

Coverage of Google Street View

Image
Coverage of Google Street View From Wikipedia, the free encyclopedia Jump to navigation Jump to search Countries and dependencies with:    mostly full coverage    partial coverage    full or partial coverage planned (official)    full or partial coverage planned (unofficial)    views of selected businesses and/or tourist attractions only    views of private businesses only    no current or planned coverage Google Street View was first introduced in the United States on May 25, 2007, and until November 26, 2008, featured camera icon markers, each representing at least one major city or area (such as a park), and usually the other nearby cities, towns, suburbs, and parks. Many areas that had coverage were represented by icons. Contents 1 Key additions 2 Timeline of introductions 2.1 2007 2.2 2008 2.3 2009 2.4 2010 2.5 2011 2.6 2012 2.7 2013 2.8 2014 2.9 20...
Read more

Full-time equivalent

Image
Full-time equivalent From Wikipedia, the free encyclopedia Jump to navigation Jump to search Full-time equivalent ( FTE ) or whole time equivalent ( WTE ) is a unit that indicates the workload of an employed person (or student) in a way that makes workloads or class loads comparable [1] across various contexts. FTE is often used to measure a worker's or student's involvement in a project, or to track cost reductions in an organization. An FTE of 1.0 is equivalent to a full-time worker or student, while an FTE of 0.5 signals half of a full work or school load. [2] Contents 1 U.S. Federal Government 2 In education 2.1 Example 3 Notes 4 References U.S. Federal Government [ edit ] In the U.S. Federal Government, FTE is defined by the Government Accountability Office (GAO) as the number of total hours worked divided by the maximum number of compensable hours in a full-time schedule as...
Read more

Surfing

Image
Surfing From Wikipedia, the free encyclopedia Jump to navigation Jump to search This article is about stand-up ocean surfing. For other uses, see Surfing (disambiguation). "Surfer" redirects here. For other uses, see Surfer (disambiguation). Surfing A surfer at the Cayucos Pier, Cayucos, California Highest governing body World Surf League (WSL) Characteristics Mixed gender Yes, separate competitions Presence Country or region Worldwide Olympic Will debut in 2020 Surfing on the Gold Coast, Queensland, Australia Surfing is a surface water sport in which the wave rider, referred to as a surfer, rides on the forward or deep face of a moving wave, which usually carries the surfer towards the shore. Waves suitable for surfing are primarily found in the ocean, but can also be found in lakes or rivers in the form of a standing wave or tidal bore. However, surfers can also utilize artifi...
Read more